title: When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Vito
authors.initials: V
authors.lastname: Amoroso
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Nicola
authors.initials: N
authors.lastname: Fazio
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Mosca
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Elisa
authors.initials: E
authors.lastname: Roca
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Spada
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Foroni
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Giorgio Maria
authors.initials: GM
authors.lastname: Agazzi
authors.affiliation: Vito Amoroso, University of Brescia at ASST Spedali Civili, Brescia, Italy; Nicola Fazio, European Institute of Oncology, Milan, Italy; Alessandra Mosca, Maggiore della Carità University Hospital, University of Eastern Piedmont, Novara, Italy; Elisa Roca, University of Brescia at ASST Spedali Civili, Brescia, Italy; Francesca Spada, European Institute of Oncology, Milan, Italy; and Chiara Foroni, Giorgio Maria Agazzi, and Alfredo Berruti, University of Brescia at ASST Spedali Civili, Brescia, Italy.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Berruti
mesh_terms: D015415:Biomarkers; D000068338:Everolimus; D006801:Humans; D018358:Neuroendocrine Tumors; D010190:Pancreatic Neoplasms
chemical_list: D015415:Biomarkers; D000068338:Everolimus